FMP
Medifast, Inc.
MED
NYSE
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is headquartered in Baltimore, Maryland.
12.12 USD
-0.14 (-1.16%)
Operating Data
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
934.84M
1.53B
1.6B
1.07B
602.46M
697.86M
808.37M
936.38M
1.08B
1.26B
Revenue %
-
63.25
4.75
-32.94
-43.8
15.84
15.84
15.84
15.84
Ebitda
134.16M
223.05M
201.84M
139.51M
2.88M
76.88M
89.06M
103.16M
119.49M
138.42M
Ebitda %
14.35
14.62
12.63
13.01
0.48
11.02
11.02
11.02
11.02
Ebit
126.89M
211.17M
184.76M
126.4M
2.88M
71.51M
82.84M
95.95M
111.15M
128.75M
Ebit %
13.57
13.84
11.56
11.79
0.48
10.25
10.25
10.25
10.25
Depreciation
7.27M
11.88M
17.08M
13.11M
-
5.37M
6.22M
7.2M
8.35M
9.67M
Depreciation %
0.78
0.78
1.07
1.22
-
0.77
0.77
0.77
0.77
Balance Sheet
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Total Cash
174.47M
109.54M
87.69M
150.04M
90.93M
84.32M
97.68M
113.14M
131.06M
151.81M
Total Cash %
18.66
7.18
5.49
14
15.09
12.08
12.08
12.08
12.08
Receivables
584k
-
-
-
-
87.19k
101k
116.99k
135.52k
156.98k
Receivables %
0.06
-
-
-
-
0.01
0.01
0.01
0.01
Inventories
53.39M
180.04M
118.86M
54.59M
42.42M
51.75M
59.94M
69.44M
80.43M
93.17M
Inventories %
5.71
11.8
7.44
5.09
7.04
7.42
7.42
7.42
7.42
Payable
36.09M
70.89M
53.12M
39.19M
23.05M
26.95M
31.22M
36.17M
41.89M
48.53M
Payable %
3.86
4.65
3.32
3.66
3.83
3.86
3.86
3.86
3.86
Cap Ex
-5.89M
-34.21M
-16.68M
-6.48M
-7.45M
-8.03M
-9.31M
-10.78M
-12.49M
-14.47M
Cap Ex %
-0.63
-2.24
-1.04
-0.6
-1.24
-1.15
-1.15
-1.15
-1.15
Weighted Average Cost Of Capital
Price
12.12
Beta
Diluted Shares Outstanding
10.96M
Costof Debt
4
Tax Rate
After Tax Cost Of Debt
2.21
Risk Free Rate
Market Risk Premium
Cost Of Equity
Total Debt
16.13M
Total Equity
132.87M
Total Capital
149M
Debt Weighting
10.82
Equity Weighting
89.18
Wacc
8.41
Build Up Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
934.84M
1.53B
1.6B
1.07B
602.46M
697.86M
808.37M
936.38M
1.08B
1.26B
Ebitda
134.16M
223.05M
201.84M
139.51M
2.88M
76.88M
89.06M
103.16M
119.49M
138.42M
Ebit
126.89M
211.17M
184.76M
126.4M
2.88M
71.51M
82.84M
95.95M
111.15M
128.75M
Tax Rate
44.78
44.78
44.78
44.78
44.78
44.78
44.78
44.78
44.78
44.78
Ebiat
97.21M
160.27M
144.11M
97.57M
1.59M
51.91M
60.12M
69.65M
80.67M
93.45M
Depreciation
7.27M
11.88M
17.08M
13.11M
-
5.37M
6.22M
7.2M
8.35M
9.67M
Receivables
584k
-
-
-
-
87.19k
101k
116.99k
135.52k
156.98k
Inventories
53.39M
180.04M
118.86M
54.59M
42.42M
51.75M
59.94M
69.44M
80.43M
93.17M
Payable
36.09M
70.89M
53.12M
39.19M
23.05M
26.95M
31.22M
36.17M
41.89M
48.53M
Cap Ex
-5.89M
-34.21M
-16.68M
-6.48M
-7.45M
-8.03M
-9.31M
-10.78M
-12.49M
-14.47M
Ufcf
80.71M
46.68M
187.92M
154.53M
-9.84M
43.73M
53.1M
61.5M
71.24M
82.52M
Wacc
8.41
8.41
8.41
8.41
8.41
Pv Ufcf
40.33M
45.18M
48.27M
51.58M
55.11M
Sum Pv Ufcf
240.47M
Terminal Value
Growth In Perpetuity Method
Long Term Growth Rate
Wacc
8.41
Free Cash Flow T1
82.94M
Terminal Value
1.05B
Present Terminal Value
700.16M
Intrinsic Value
Enterprise Value
940.63M
Net Debt
-74.8M
Equity Value
1.02B
Diluted Shares Outstanding
10.96M
Equity Value Per Share
92.62
Projected DCF
92.62 0.869%
